Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”) a commercial-stage company engaged in...
Day: December 8, 2021
Talis Biomedical Announces Leadership Transition
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health...
Ocuphire Expands Prestigious Medical Advisory Board with Six New KOLs to Support Advancement of Late-Stage Ophthalmic Assets Nyxol® and APX3330
FARMINGTON HILLS, Mich, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused...
Palisade Bio Granted New U.S. Patent Covering Protease Inhibitor LB1148 for Treating Adhesions and Postoperative Ileus
Issuance of Additional U.S. Patent No11,202,768 Further Bolsters Palisade Bio’s Patent Portfolio The Company Continues to Advance LB1148 for Key...
Monopar Advances Dosing of Camsirubicin to Higher Level Than Tested In Any Previous Clinical Trial
WILMETTE, Ill., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug...
Dentsply Sirona and 3Shape Expand Their Strategic Partnership with Seamless Connectivity for Dentists and Dental Labs
Dentsply Sirona’s intraoral Primescan and Omnicam scanners now integrate directly with 3Shape’s lab software, delivering better workflows and patient outcomes.CHARLOTTE,...
InnerScope Hearing Technologies (OTC: INND) Receives Walmart Purchase Orders of $277,000+ for In-Store Product Sales
ROSEVILLE, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging...
Internationally Recognized Dr. Peter Centre in Vancouver Goes Live with VitalHub’s eMAR
TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is proud to announce that...
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference...
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
The University of Colorado Anschutz Medical Campus and Orange Grove Bio to Collaborate on Development and Commercialization of Novel Therapies
Collaboration will Leverage Work of World-Class Researchers at CU Anschutz to Grow Colorado Biotech Ecosystem through Company Creation and Drug...
Ikena Appoints Michelle Zhang, Ph.D., Industry and Company Veteran, as Chief Scientific Officer
Dr. Zhang steps into the CSO role after spending more than five years at Ikena in research and development leadership...
Passage Bio Announces Pipeline Expansion and Clinical Program Update
Exercised two additional options with University of Pennsylvania’s Gene Therapy Program aligned with company’s focus on CNS diseases with high...
IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria
– Grant Agreement with the Bill & Melinda Gates Foundation Aims to Leverage IGM’s Engineered IgM and IgA Antibodies to...
Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery
Accretive Acquisition of Award-Winning Producer of Distilled Spirits Expands Tilray’s U.S. Offerings into the On-Trend Spirits Category Tilray’s Diversified, Growing...
Pfizer and BioNTech Provide Update on Omicron Variant
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two...
Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform
Meet Proteona at ASH 2021 Proteona announced one oral presentation and two poster presentations at ASH 2021 SINGAPORE, Dec. 08,...
Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Roche’s Anti-PD-L1 Checkpoint Inhibitor Atezolizumab
HEIDELBERG, Germany, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) a clinical-stage immuno-oncology company committed to giving patients...
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
Signing Ceremony KT Senior EVP and Head of AI/DX Jae-ho Song and NeuroSigma Director, C. Thomas Paschall execute investment documents...
